{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:10:19Z","timestamp":1767665419851,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.braindev.2008.08.016","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T18:40:04Z","timestamp":1223750404000},"page":"634-637","source":"Crossref","is-referenced-by-count":18,"title":["Benefits of FK 506 for refractory eye symptoms in a young child with ocular myasthenia gravis"],"prefix":"10.1016","volume":"31","author":[{"given":"Keiko","family":"Ishigaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Shishikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terumi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2008.08.016_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.clineuro.2004.07.013","article-title":"Benefits of FK506 (tacrolimus) for residual, cyclosporine- and prednisone-resistant myasthenia gravis: one-year follow up of an open-label study","volume":"107","author":"Ponseti","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.braindev.2008.08.016_bib2","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1212\/01.WNL.0000160392.32894.6D","article-title":"Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis","volume":"664","author":"Ponseti","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2008.08.016_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jns.2006.03.010","article-title":"Long-term therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis","volume":"247","author":"Tada","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.braindev.2008.08.016_bib4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.braindev.2006.02.001","article-title":"Successful treatment of a 2-year-old girl with intractable myasthenia gravis using tacrolimus","volume":"28","author":"Kakisaka","year":"2006","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2008.08.016_bib5","first-page":"300","article-title":"A child with generalized myasthenia gravis successfully treated with tacrolimus (in Japanese)","volume":"39","author":"Goto","year":"2007","journal-title":"No To Hattatsu (Tokyo)"},{"key":"10.1016\/j.braindev.2008.08.016_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1749-6632.1998.tb11020.x","article-title":"A treatment algorithm for autoimmune myasthenia gravis in childhood","volume":"841","author":"Andrews","year":"1998","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.braindev.2008.08.016_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s004150050135","article-title":"Outcome in juvenile-onset myasthenia gravis: a retrospective study with long-term follow up of 79 patients","volume":"244","author":"Lindner","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2008.08.016_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01954388","article-title":"Immunosuppressive treatment for juvenile myasthenia gravis","volume":"151","author":"Badurska","year":"1992","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.braindev.2008.08.016_bib9","first-page":"1222","article-title":"Myasthenia gravis \u2013 latent general type (in Japanese)","volume":"31","author":"Segawa","year":"1973","journal-title":"Naika"},{"key":"10.1016\/j.braindev.2008.08.016_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2003.10.004","article-title":"A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan","volume":"110","author":"Shinomiya","year":"2004","journal-title":"Clin Immunol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760408002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760408002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T05:51:12Z","timestamp":1545717072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760408002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0387760408002052"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2008.08.016","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}